Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Goodman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Mental Illness|December 6, 2014
ADHD-hyperactive/impulsive subtype in adultsChristopher Gibbins, Margaret D Weiss, David W Goodman, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorderMargaret D Weiss, Christopher Gibbins, David W Goodman, et al.
The Journal of Clinical Psychiatry|November 18, 2008
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderLenard A Adler, David W Goodman, Scott H Kollins, et al.
The Journal of Clinical Psychiatry|February 9, 2012
Lifespan persistence of ADHD: the life transition model and its applicationAtilla Turgay, David W Goodman, Philip Asherson, et al.
Journal of Attention Disorders|February 21, 2023
Progress and Pitfalls in the Provision of Quality Care for Adults With Attention Deficit Hyperactivity Disorder in Primary CareElisabeth F Callen, Tarin L Clay, Jillian Alai, et al.
Neuropsychiatric Disease and Treatment|December 24, 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylateRichard H Weisler, Lenard A Adler, Scott H Kollins, et al.
BMC Psychiatry|January 30, 2013
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGreg W Mattingly, Richard H Weisler, Joel Young, et al.
Journal of Attention Disorders|December 5, 2018
The Adult ADHD Quality Measures InitiativeStephen V Faraone, Michael J Silverstein, Kevin Antshel, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversiesSamuele Cortese, Mark A Bellgrove, Isabell Brikell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Mental Illness|December 6, 2014
ADHD-hyperactive/impulsive subtype in adultsChristopher Gibbins, Margaret D Weiss, David W Goodman, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorderMargaret D Weiss, Christopher Gibbins, David W Goodman, et al.
The Journal of Clinical Psychiatry|November 18, 2008
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderLenard A Adler, David W Goodman, Scott H Kollins, et al.
The Journal of Clinical Psychiatry|February 9, 2012
Lifespan persistence of ADHD: the life transition model and its applicationAtilla Turgay, David W Goodman, Philip Asherson, et al.
Journal of Attention Disorders|February 21, 2023
Progress and Pitfalls in the Provision of Quality Care for Adults With Attention Deficit Hyperactivity Disorder in Primary CareElisabeth F Callen, Tarin L Clay, Jillian Alai, et al.
Neuropsychiatric Disease and Treatment|December 24, 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylateRichard H Weisler, Lenard A Adler, Scott H Kollins, et al.
BMC Psychiatry|January 30, 2013
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGreg W Mattingly, Richard H Weisler, Joel Young, et al.
Journal of Attention Disorders|December 5, 2018
The Adult ADHD Quality Measures InitiativeStephen V Faraone, Michael J Silverstein, Kevin Antshel, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversiesSamuele Cortese, Mark A Bellgrove, Isabell Brikell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
Pageof 4